Treatment with bosentan in a patient with thalassemia intermedia and pulmonary arterial hypertension

被引：20
|
作者：
Anthi, Anastasia [1 ,2 ]
Tsangaris, Iraklis [1 ,2 ]
Hamodraka, Eftichia S. [3 ]
Lekakis, John [2 ,3 ]
Armaganidis, Apostolos [1 ,2 ]
Orfanos, Stylianos E. [1 ,2 ]
机构：
[1] Univ Athens, Sch Med, Dept Crit Care 2, Attikon Gen Hosp, GR-11527 Athens, Greece
[2] Univ Athens, Sch Med, Pulm Hypertens Clin, Attikon Gen Hosp, GR-11527 Athens, Greece
[3] Univ Athens, Sch Med, Dept Cardiol 2, Attikon Gen Hosp, GR-11527 Athens, Greece
来源：
BLOOD | 2012年 / 120卷 / 07期
关键词：
SICKLE-CELL-DISEASE; SILDENAFIL;
D O I：
10.1182/blood-2012-04-422568
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1531 / 1532
页数：4
相关论文
共 50 条
  • [21] Treatment of sarcoidosis-associated pulmonary arterial hypertension with Bosentan
    Bimenyuy, Christian
    Bourbonnais, Julie
    Samavati, Lobelia
    CHEST, 2007, 132 (04) : 482S - 483S
  • [22] Bosentan treatment in pulmonary arterial hypertension secondary to systemic sclerosis
    Piludu, G.
    Nalli, E.
    Amoresano, D.
    Farci, M.
    Muttini, T.
    D'Aietti, I
    Mura, N.
    Loddo, M.
    Giacco, G.
    ALLERGY, 2008, 63 : 353 - 353
  • [23] Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension
    Caterina Naclerio
    Salvatore D’Angelo
    Silvano Baldi
    Gianluigi Tagliamonte
    Salvatore Scarpato
    Clinical Rheumatology, 2010, 29 : 687 - 690
  • [24] Efficacy of bosentan in the treatment of a patient with mixed connective tissue disease complicated by pulmonary arterial hypertension
    Naclerio, Caterina
    D'Angelo, Salvatore
    Baldi, Silvano
    Tagliamonte, Gianluigi
    Scarpato, Salvatore
    CLINICAL RHEUMATOLOGY, 2010, 29 (06) : 687 - 690
  • [25] Bosentan therapy for pulmonary arterial hypertension
    Cohen, H
    Chahine, C
    Hui, A
    Mukherji, R
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (11) : 1107 - 1119
  • [26] Bosentan Inducing Autoimmune Hepatitis in a Patient with Idiopathic Pulmonary Arterial Hypertension
    de Araujo, Alexandre
    Mantovani, Augusto
    Schmidt Cerski, Carlos Thadeu
    Lopes, Antonio Barros
    Bortoncello, Luiza Cristina
    Gazzana, Marcelo Basso
    Cheinquer, Hugo
    JOURNAL OF GASTROINTESTINAL AND LIVER DISEASES, 2018, 27 (01) : 89 - 92
  • [27] PALOSURAN TREATMENT, EFFECTIVE AS BOSENTAN IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH) MODEL
    Onat, A. Mesut
    Pehlivan, Y.
    Demir, T.
    Kaplan, D. Sinan
    Orkmez, M.
    Turkebeyler, I. Halil
    Taysi, S.
    Kisacik, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 328 - 329
  • [28] Bosentan for the treatment of pulmonary arterial hypertension associated with congenital cardiac disease
    Kotlyar, Eugene
    Sy, Raymond
    Keogh, Anne M.
    Kermeen, Fiona
    Macdonald, Peter S.
    Hayward, Christopher S.
    McNeil, Keith D.
    Celermajer, David S.
    CARDIOLOGY IN THE YOUNG, 2006, 16 (03) : 268 - 274
  • [29] Treatment of pulmonary arterial hypertension with bosentan: from pathophysiology to clinical evidence
    Provencher, S
    Sitbon, O
    Simonneau, G
    EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (08) : 1337 - 1348
  • [30] Long-term bosentan treatment in children with pulmonary arterial hypertension
    Standing, JF
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (09) : 1914 - 1915
12345